Combination of Two Cancer Immunotherapy Drugs Doubles Mesothelioma Survival in Lab Animals

Researchers from Massachusetts General Hospital believe that they have made a significant breakthrough in the battle against malignant mesothelioma by combining two different immunotherapy drugs that approach cancer from different angles: one activates an immune response while the other blocks a pathway that helps the rare form of cancer evade the immune system. Speaking of…

The post Combination of Two Cancer Immunotherapy Drugs Doubles Mesothelioma Survival in Lab Animals appeared first on Mesothelioma.net.



from Mesothelioma.net https://ift.tt/2H3NISp
via IFTTT
Combination of Two Cancer Immunotherapy Drugs Doubles Mesothelioma Survival in Lab Animals Combination of Two Cancer Immunotherapy Drugs Doubles Mesothelioma Survival in Lab Animals Reviewed by Unknown on April 02, 2018 Rating: 5

No comments:

Powered by Blogger.